Shalby Ltd.
Snapshot View

143.95 +1.15 ▲0.8%

09 February 2023, 01:55:59 PM
Volume: 81,736

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.shalby.org
Market Cap 1,560.74 Cr.
Enterprise Value(EV) 1,598.40 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 5.93 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 24.38 Trailing Twelve Months Ending 2022-12
Industry PE 46.98 Trailing Twelve Months Ending 2022-12
Book Value / Share 86.11 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.68 Calculated using Price: 144.50
Dividend Yield 0.69 Period Ending 2022-03
No. of Shares Subscribed 10.80 Cr. 108,009,770 Shares
FaceValue 10
Company Profile
The company is one of the leading multi-specialty chains of hospitals in India. Its hospitals are tertiary care hospitals, few of which also offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.81%
1 Week
+3.08%
1 Month
-10.92%
3 Month
+0.59%
6 Month
+17.51%
1 Year
+3.60%
2 Year
+31.76%
5 Year
-38.42%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 31.21 15.92 19.50 12.60 7.81 4.13 3.49 5.19 6.31
Return on Capital Employed (%) 38.23 21.84 13.34 12.21 9.15 6.94 7.49 6.85 9.08
Return on Assets (%) 20.47 8.64 8.49 4.61 4.42 3.12 2.72 4.05 4.60

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 141 168 205 251 751 780 799 835 876 898
Non Curr. Liab. 33 90 207 291 140 130 144 150 234 156
Curr. Liab. 40 90 92 199 138 88 83 82 172 152
Minority Int. 3 2 0 -1 0 0 0 0 0 0
Equity & Liab. 217 351 504 741 1,030 998 1,027 1,066 1,282 1,205
Non Curr. Assets 154 289 440 582 794 801 793 795 831 736
Curr. Assets 63 63 64 159 236 197 234 271 451 470
Misc. Exp. not W/O
Total Assets 217 351 504 741 1,030 998 1,027 1,066 1,282 1,205

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 259 275 290 324 378 462 487 431 699 769
Other Income 3 2 2 7 10 9 17 9 12 18
Total Income 262 278 293 331 388 472 504 440 711 786
Total Expenditure -196 -208 -235 -252 -299 -379 -404 -344 -577 -633
PBIDT 66 70 58 78 89 93 100 96 134 153
Interest -2 -5 -10 -11 -12 -9 -7 -5 -8 -8
Depreciation -11 -21 -11 -17 -23 -33 -36 -37 -43 -46
Taxation -14 -18 0 -22 -15 -19 -29 -13 -25 -34
Exceptional Items -4
PAT 38 25 36 29 39 32 28 42 54 64
Minority Interest 1 1 1 1 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 39 26 38 30 39 32 28 42 54 64
Adjusted EPS 11 7 4 3 4 3 3 4 5 6

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 95 5 123 5 60 14 43 55 79 19
Cash Fr. Inv. -9 -26 -62 -98 -153 -237 1 -31 -51 -60
Cash Fr. Finan. -86 24 -39 75 96 222 -51 -22 -30 90
Net Change 0 3 22 -19 3 0 -6 3 -2 49
Cash & Cash Eqvt 2 6 27 9 12 12 5 8 6 56

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 79.45 79.45 74.07 74.02 74.02 74.02 74.04 74.04 74.12
Public 20.55 20.55 25.93 25.98 25.98 25.98 25.97 25.97 25.88
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 08 Feb 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Shalby Limited has informed the Exchange about Schedule of meet
Tue, 07 Feb 2023
Updates
Shalby Limited has informed the Exchange regarding 'Update on Vrundavan Shalby Hospitals Limited Wholly owned Subsidiary'.
Mon, 06 Feb 2023
Updates
Shalby Limited has informed the Exchange regarding 'Update on Vrundavan Shalby Hospitals Limited Wholly owned Subsidiary'.

Technical Scans View Details >>

Wed, 08 Feb 2023
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Entering 52 Week High Zone Close Entering 52 Week High Zone
High Decrease in 1 Month High Decrease in 1 Month
CCI Bullish CCI Bullish

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,006.90 -0.6%
Cipla Ltd. 83,886.47 1,024.90 -1.4%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,507.90 +0.4%
Divi's Laboratories Ltd. 74,340.49 2,815.95 +0.6%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,397.60 +0.1%
Torrent Pharmaceuticals Ltd. 52,675.65 1,543.80 -0.8%
Zydus Lifesciences Ltd. 47,993.66 473.30 -0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,006.90 -0.6%
Cipla Ltd. Consolidated 2022-12 31.80 1,024.90 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,507.90 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,815.95 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,397.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,543.80 -0.8%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 473.30 -0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,006.90 -0.6%
Cipla Ltd. Consolidated 2022-12 3.70 1,024.90 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,507.90 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,815.95 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,397.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,543.80 -0.8%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 473.30 -0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,006.90 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,024.90 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,507.90 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,815.95 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,397.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,543.80 -0.8%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 473.30 -0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.90 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.90 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,507.90 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,815.95 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,397.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.80 -0.8%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.30 -0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.90 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.90 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,507.90 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,815.95 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,397.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.80 -0.8%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.30 -0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,006.90 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,024.90 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,507.90 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,815.95 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,397.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,543.80 -0.8%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 473.30 -0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,006.90 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,024.90 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,507.90 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,815.95 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,397.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,543.80 -0.8%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 473.30 -0.2%

FAQ's On Shalby Ltd.

What is Shalby share price?

Can I buy Shalby shares now?

What is the Dividend Yield of Shalby?

What is the Market Cap of Shalby?

What are the key metrics to analyse Shalby?

What is the 52 Week High and Low of Shalby?

What is the trend of Shalby share price?